After attending the following session individuals should be able to: Identify ways to prevent medication abuse in your patients and drug diversion within your practice.Outline strategies for assessing and counseling patients on the use of OTC products.Describe patient’s attitudes about monitoring and diagnostics for self-care.Describe the impact of poor adherence on clinical and economic outcomes for patient and stakeholders.Discuss new personal health care technologies and the impact they may have on patient outcomes.Describe the mechanism of action and indications for newly approved drugs.Identify challenges and safety concerns regarding the medication approval, post-market surveillance processes, and FDA activities.Describe common sources for miscommunication in health care that can lead to potentially serious medical errors.Describe the benefits and limitations of collaborative practice models in various patient care settings.Conference Sessions generally take place during the days at sea (as cruise itinerary allows) to avoid conflicts with Ports of Call or evening entertainment.